Are there patients on immunotherapy for whom you are NOT recommending the COVID-19 vaccine?

Do current or resolved immune-related adverse events (irAEs) influence your decision?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

What is your approach to IV fluid management for the treatment of hypercalcemia of malignancy?

How do you evaluate and manage oropharyngeal mucositis related to chemotherapy and radiation?

When do you refer patients back to their PCP for the predominant management of their medical care following completion of oncologic or BMT treatment?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.